| TAVALISSE RIGEL PHARMACEUTICALS INC.
1823324 17 Feb 2017 | on 08 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of immunologic diseases, namely autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel disease, coeliac disease, ulcerative colitis; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders, namely, thrombocytopenia, leukemia, autoimmune hemolytic anemia. | | | TAVALISSE & CIRCLE DESIGN RIGEL PHARMACEUTICALS INC.
1862035 11 Oct 2017 | on 20 Dec 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment of immune system diseases and disorders, namely, autoimmune diseases and immunologic deficiency syndromes; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel disease, coeliac disease, ulcerative colitis; anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for the treatment of hematological conditions, diseases and disorders, namely, thrombocytopenia, leukemia, autoimmune hemolytic anemia. | | 
